|
|
||||||||
|
|
|||||||||
|
|
Oncology-Basic Science: Basic ScienceIn-vivo Models |
1 BIRC, Univ. Fukui, Eiheiji, Japan; 2 MIC, NIRS, Chiba, Japan
206
Objectives: 11C-acetate PET is traditionally used for myocardial studies. In myocardium, mitochondrial acetyl-CoA synthetase (Acss) 1 contributes to acetate tracer uptake. Meanwhile, the 11C-acetate PET is used for tumor diagnosis; however, the exact mechanism has been unclear. From our data, tumor cells expressed cytosolic Acss2, but not Acss1. In tumor cells, Acss2 was up-regulated under hypoxia and able to mediate an acetate-producing pathway with energy synthesis, which suggests that Acss2 would control both anabolism and catabolism of acetate coordinately. In this study, we examined a role of Acss2 in tumor acetate tracer uptake and considered a possibility of acetate imaging for visualizing tumor hypoxic metabolism.
Methods: Four mouse tumor cell lines (LLC1, B16, Colon-26, C127I) and a fibroblast cell line as control were used. To suppress Acss2, RNAi was performed. For 14C-acetate uptake study, cells were preincubated and some cells were treated by 2 h hypoxia, additionally. Cells were incubated in medium containing 37kBq 14C-acetate for 1 h under the same condition. Then, radioactivity was measured.
Results: In tumor cells, 14C-acetate uptake was increased under hypoxia than normoxia, but not in control. The pattern of 14C-acetate uptake was mostly correlated to Acss2 expression pattern. In Acss2 RNAi tumor cells, 14C-acetate uptake was decreased, regardless of O2 conditions, compared with control RNAi. This implicated that Acss2 participated in acetate tracer uptake in tumor cells.
Conclusions: We found that Acss2 plays significant roles in acetate tracer uptake in tumor cells, indicating that tumor cells possess a different acetate uptake mechanism from that in myocardium. These evidences suggest that acetate imaging can reflect a tumor-specific acetate metabolism activated under hypoxia.
| ||||||||||||||||||||||||||||||||||||||